Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue    
Total revenue $ 90
Operating expenses:    
Research and development, net of reimbursements 21,124 30,045
General and administrative 15,213 12,076
Total operating expenses 36,337 42,121
Loss from operations (36,247) (42,121)
Other income:    
Interest income – net 2,360 3,878
Total other income 2,360 3,878
Net loss $ (33,887) $ (38,243)
Net loss per common share – basic (in Dollars per share) $ (1.09) $ (1.27)
Net loss per common share – diluted (in Dollars per share) $ (1.09) $ (1.27)
Weighted average common shares outstanding – basic (in Shares) 31,195,891 30,070,028
Weighted average common shares outstanding – diluted (in Shares) 31,195,891 30,070,028
Revenue    
Revenue    
Total revenue
Other Revenue    
Revenue    
Total revenue $ 90